Healthcare
Harm Reduction Is Vital on World Vape Day
Tobacco harm reduction products like e-cigarettes are effective tools that help adults successfully quit smoking.
CAGW Requests that the U.S. International Trade Commission Should not Expand the TRIPS Waiver
Expanding the COVID-19 TRIPS Wavier will further harm future biopharmaceutical research and development.
Recognizing Women’s Medical Innovations on World IP Day
Intellectual property rights must be protected to encourage future research and development of life saving cures.
West Virginia Should Continue to Repeal Burdensome CON Laws
SB 613 partially repeals West Virginia's harmful Certificate of Need laws.
Attacking PBMs Won’t Result in Lower Drug Costs
SB 1550 will negatively impact Florida's private sector healthcare market and ultimately harm patients.
New York Takes the Wrong Approach to Tobacco
New York's proposed tax and flavor ban would negatively impact tobacco harm reduction efforts and public health.
The Cantwell-Grassley PBM Bill is a Wolf in Sheep’s Clothing
A Bill introduced in the Senate takes aim at PBMS and private sector healthcare.
Patients Pay the Ultimate Price for Price Controls
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
Oregon Lawmakers Put Fear Over Facts
Oregon's ban of flavored tobacco products would hurt harm reduction efforts.
Americans are Still Getting Conned by Certificate of Need Laws
Certificate of need laws increase healthcare costs and reduce access to quality care.
CCAGW Year in Review in the States
In 2022, CCAGW helped protect taxpayers with wins on data privacy, broadband spending, drug price controls, and reducing red tape.
California Got it Wrong on Flavored Tobacco
California's permanent ban of flavored tobacco products hurts harm reduction efforts.
